Bicycle Therapeutics plc (BCYC)

Bicycle Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	890.86	526.42	339.15	438.68	135.99	92.12
Cash & Short-Term Investments	890.86	526.42	339.15	438.68	135.99	92.12
Cash Growth	55.72%	55.22%	-22.69%	222.58%	47.63%	45.34%
Accounts Receivable	-	-	2.05	1	5.46	0.2
Other Receivables	57.98	24.04	19.16	10.91	9.18	6.94
Receivables	57.98	24.04	21.21	11.91	14.63	7.15
Prepaid Expenses	17.35	11.41	9.02	7.97	5.1	4.88
Total Current Assets	966.19	561.87	369.38	458.56	155.72	104.15
Property, Plant & Equipment	20.61	27.68	32.77	17.79	3.61	4.35
Other Long-Term Assets	9.94	5.79	8.46	3.45	1.82	1.7
Total Assets	996.75	595.34	410.61	479.79	161.15	110.19
Accounts Payable	5.71	13.05	6.47	2.72	1.37	1.95
Accrued Expenses	33.36	26.38	21.86	11.29	10.58	5.44
Current Portion of Leases	5.55	4.88	3.13	2.38	0.84	0.64
Current Unearned Revenue	11.38	24.98	20.42	19.27	10.14	0.73
Other Current Liabilities	0.4	0.26	1.47	0.57	0.21	0.07
Total Current Liabilities	56.41	69.54	53.34	36.24	23.13	8.82
Long-Term Debt	-	30.7	30.32	29.87	14.51	-
Long-Term Leases	5.53	9.38	10.89	12.08	0.43	1.25
Long-Term Unearned Revenue	97.81	110.22	41.46	52.07	25.02	4.93
Other Long-Term Liabilities	5.96	4.58	3.83	3.28	2.61	2
Total Liabilities	165.71	224.41	139.83	133.54	65.69	17
Common Stock	0.89	0.55	0.39	0.38	0.27	0.23
Additional Paid-In Capital	1,462	883.45	601.11	567.64	249.95	195.06
Retained Earnings	-628.94	-511.76	-331.1	-218.38	-151.56	-100.55
Comprehensive Income & Other	-3.19	-1.3	0.39	-3.39	-3.19	-1.54
Total Common Equity	831.03	370.93	270.78	346.25	95.46	93.2
Shareholders' Equity	831.03	370.93	270.78	346.25	95.46	93.2
Total Liabilities & Equity	996.75	595.34	410.61	479.79	161.15	110.19
Total Debt	11.09	44.96	44.33	44.34	15.78	1.89
Net Cash (Debt)	879.78	481.47	294.83	394.34	120.22	90.23
Net Cash Growth	67.13%	63.30%	-25.24%	228.03%	33.24%	42.36%
Net Cash Per Share	17.07	13.53	9.94	15.73	6.28	8.17
Filing Date Shares Outstanding	69.05	42.59	30.02	29.6	23.09	17.99
Total Common Shares Outstanding	69.02	42.43	29.87	29.58	21.09	17.99
Working Capital	909.79	492.33	316.04	422.32	132.59	95.33
Book Value Per Share	12.04	8.74	9.06	11.71	4.53	5.18
Tangible Book Value	831.03	370.93	270.78	346.25	95.46	93.2
Tangible Book Value Per Share	12.04	8.74	9.06	11.71	4.53	5.18
Machinery	18.59	16.91	16.24	7.11	5.97	4.68
Leasehold Improvements	11.57	11	10.74	0.81	0.38	0.3

Source: S&P Capital IQ. Standard template. Financial Sources.